713-1269

completed

Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 713 (USA) (Dr. Kowalski) · consented 2014-01-27

Adverse events

Serious AEs

Open data queries

Luna dropout signal

–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-02 (study day 7.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-18 (study day 82.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-10 (study day 165.0); relationship: REMOTE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-10 (study day 165.0); relationship: REMOTE

mild assessed 2026-08-18

Mild SHOULDER PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-01 (study day 126.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate SHOULDER PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-01 (study day 126.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.